Results 41 to 50 of about 211,160 (222)
Current Oncology, 2022 Background/Aim: Patients with uterine sarcoma comprise 2–5% of all patients with uterine malignancies; however, the morbidity of uterine sarcoma is low compared with that of other gynecological cancers.
Saya Tamura +5 more
doaj +1 more source
A Case Report of a Severely Aggressive Uterine Sarcoma at an Unusual Age [PDF]
Journal of Kerman University of Medical Sciences, 2016 Uterine sarcomas are very unique tumors with mesodermial origin and accounting for 2-6% of uterine cancers. In general, uterine sarcomas are the most malignant tumors of the uterus.
zahra honarvar, Mohades Peydayesh
doaj
Seroprevalence of Kaposi sarcoma-associated herpesvirus and other serologic markers in the Brazilian Amazon. [PDF]
, 2009 To determine the presence of Kaposi sarcoma-associated herpesvirus (KSHV) and other serologic markers, we tested serum specimens of 339 Amerindians, 181 rural non-Amerindians, and 1,133 urban blood donors (13 Amerindians) in the Brazilian Amazon.
Mascheretti, Melissa +27 more
core +1 more source
A rare diagnosis with a common presentation: a case report on uterine sarcoma [PDF]
, 2021 Uterine sarcomas are rare soft tissue tumors which constitute 3% to 7% of overall uterine malignancies. Endometrial stromal sarcoma (ESS) is a rare type of uterine sarcoma arising from the mesodermal component of the body of the uterus.
Gopalan, Ushadevi +3 more
core +1 more source
Advances in the Preoperative Identification of Uterine Sarcoma
, 2022 SIMPLE SUMMARY: As a lethal malignant tumor, uterine sarcomas lack specific diagnostic criteria due to their similar presentation with uterine fibroids, clinicians are prone to make the wrong diagnosis or adopt incorrect treatment methods, which leads to
Wang, Zijie +3 more
core +1 more source
Inhibition of uterine sarcoma cell growth through suppression of endogenous tyrosine kinase B signaling. [PDF]
PLoS ONE, 2012 Uterine leiomyosarcoma is an aggressive tumor typically found at advanced stages due to difficulties with early diagnosis. Because uterine leiomyosarcoma is resistant to conventional radiation and chemotherapy, the development of more potent medical ...
Kenichi Makino +5 more
doaj +1 more source
Uterine carcinosarcoma associated with pelvic radiotherapy for sacral chordoma: A case report
Taiwanese Journal of Obstetrics & Gynecology, 2012 Objective: Postirradiation sarcoma of the female genital tract is rare, but a recognized event. Most reported cases have been associated with history of radiotherapy for various gynecologic conditions, particularly cancer of the uterine cervix and ...
Korhan Kahraman +3 more
doaj +1 more source
Frontiers in Oncology, 2020 BackgroundUterine sarcoma is a rare gynecologic tumor with a high degree of malignancy. There is a lack of effective prognostic tools to predict early death of uterine sarcoma.MethodsData on patients with uterine sarcoma registered between 2004 and 2015 ...
Zixuan Song +3 more
doaj +1 more source
Cancer‐associated mutations in endometriosis reframe a benign disease through molecular oncology
Molecular Oncology, EarlyView.This review aims to comprehensively analyse cancer‐associated somatic mutations (CAMs) present in endometriotic lesions, emphasizing their biological roles, spatial distribution and implications for translational applications in medicine. By contextualizing a benign state within a genomic framework, this analysis seeks to establish its value as a ...
Clarissa Mujacic +15 more
wiley +1 more source
Molecular Oncology, EarlyView.This study identifies ARHGAP5, in addition to the frequently mutated ARHGAP35, as significantly mutated in endometrial cancer. Mutations in both genes co‐occur and are associated with their correlated downregulation. Functional CRISPR studies show that both paralogs regulate similar pathways, including actin cytoskeleton organization.
Mathilde Pinault +12 more
wiley +1 more source